Companies / Voyager Therapeutics, Inc.

Voyager Therapeutics, Inc.

Nasdaq: VYGRCIK 1640266LEXINGTON, MAvoyagertherapeutics.com ↗

Financials · FY2025

Revenue$40.37M
Net income$-119.72M
Total debt—
Cash$35.77M
Diluted EPS$-2.04
Shares outstanding61.6M

Ownership

61.6M shares outstanding · as of Jul 30, 2026
1.4%Insiders
Ownership
Insiders1.41%867,712
10%+ / strategic6.49%4,000,000
Institutions52.16%32,142,584
Public float39.94%24,607,652

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 9

View all →
Insider% of sharesShares
Sandrock AlfredCEOPresident and CEO · Director
0.79%484,060
Swartz RobinCOO & CBO
0.32%199,738
Ferguson TobyChief Medical Officer
0.30%183,914
Jorgensen Nathan D.FormerChief Financial Officer
0.25%151,416
Carter Todd AlfredFormerChief Scientific Officer
0.24%145,718
Geraghty James aDirector
——
Pierce GlennDirector
——
Scangos George aDirector
——
Shiferman Gregory L.FormerSVP and General Counsel
——

Institutional holders 130

View all →
HolderValue% of shares
BlackRock, Inc.$18.10M8.39%
EcoR1 Capital, LLC$15.73M6.50%
Armistice Capital, LLC$15.72M6.49%
Millennium Management LLC$13.23M5.56%
Vanguard Group Inc$12.84M5.30%
Vestal Point Capital, LP$5.80M2.39%
Erste Asset Management GmbH$4.72M1.94%
Opaleye Management Inc.$4.70M1.94%
Dimensional Fund Advisors LP$4.26M1.76%
Geode Capital Management, LLC$4.05M1.70%

Activity

View all →
InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ΔPosition afterImpact
Feb 24, 2026Sandrock Alfred
CEO
SellCommon Stock$53.8K-14K
-2.85%
484,060
0.79% of shares
low
Feb 10, 2026Sandrock Alfred
CEO
SellCommon Stock$46.1K-12K
-2.33%
509,989
0.83% of shares
low
Feb 18, 2026Sandrock Alfred
CEO
SellCommon Stock$40.0K-12K
-2.30%
498,257
0.81% of shares
low
Feb 24, 2026Swartz Robin
Executive
SellCommon Stock$24.3K-6K
-3.13%
199,738
0.32% of shares
low
Feb 24, 2026Jorgensen Nathan D.
Executive
SellCommon Stock$17.6K-5K
-2.99%
151,416
0.25% of shares
low
Feb 10, 2026Swartz Robin
Executive
SellCommon Stock$17.6K-5K
-2.13%
210,078
0.34% of shares
low
Feb 24, 2026Carter Todd Alfred
Executive
SellCommon Stock$15.7K-4K
-2.78%
145,718
0.24% of shares
low
Feb 10, 2026Carter Todd Alfred
Executive
SellCommon Stock$13.6K-4K
-2.25%
153,193
0.25% of shares
low

5%+ ownership events

Schedule 13D / 13G
FilerStance% of classSharesDate
Vanguard Group IncPassive13G/A—0—
Integrated Core Strategies (US) LLCPassive13G———
EcoR1 Capital, LLCPassive13G/A———
Armistice Capital, LLCPassive13G/A—4,000,000—

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
VYGR——92915B106—